🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, open, multi-center, single arm trial. The trea...
Status
Recruiting
Location
the First Affiliated Hospital of Wenzhou Medical University
Start Date
2021-11-27
Trial ID
NCT06234137
Treatments Being Tested
This clinical trial aims to evaluate the efficacy, safety of Pyrotinib in c...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2019-07-01
Trial ID
NCT03843749
Treatments Being Tested
The main purpose of this study was to observe the efficacy and safety of tr...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2020-04-01
Trial ID
NCT04293276
This study is a randomized, open-label, phase II study, comparing the effic...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03910712
Treatments Being Tested
Trastuzumab resistance, which is a common therapeutic challenge in HER2 pos...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-06-26
Trial ID
NCT04001621
Treatments Being Tested
Disitamab Vedotin（RC48）combined with EGFR or HER2 TKIs in locally advanced ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-02-01
Trial ID
NCT06185400
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER1, HER2 an...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2018-11-01
Trial ID
NCT04033172
Treatments Being Tested
Various driver gene mutations have been identified in lung cancer. Among th...
Status
Unknown
Location
Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University
Start Date
2020-06-30
Trial ID
NCT04382300
Treatments Being Tested
To explore the real world data of trastuzumab Combined With Trastuzumab And...
Status
Unknown
Location
Multiple Locations
Start Date
2021-01-01
Trial ID
NCT04609540
Treatments Being Tested
This study evaluated the clinical benefits of intravenous administration of...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-15
Trial ID
NCT06537674
Treatments Being Tested